TABLE 3.
Comparison of CA and in-house PCR to the adapted gold standard
Specimens | Amplification system | No. of adapted gold standard-positive specimensa that were PCR:
|
No. of adapted gold standard-negative specimensb that were PCR:
|
Sensitivity (%) | Specificity (%) | NPV (%) | PPV (%) | ||
---|---|---|---|---|---|---|---|---|---|
Positive | Negative | Positive | Negative | ||||||
All (n = 1,527) | CA | 67 | 34 | 4 | 1,422 | 66.33 | 99.71 | 97.66 | 94.36 |
In house | 92 | 9 | 2 | 1,424 | 91.08 | 99.85 | 99.37 | 97.87 | |
Smear positive | CA | 28 | 4 | 0 | 0 | 87.50 | 99.37 | ||
(n = 32)c | In house | 31 | 1 | 0 | 0 | 96.87 | 99.37 | ||
Smear negative | CA | 39 | 30 | 4 | 1,422 | 56.52 | 99.71 | 97.93 | 90.69 |
(n = 1,495)d | In house | 61 | 8 | 2 | 1,424 | 88.40 | 99.85 | 99.44 | 96.82 |
Specimens from patients with TB (for a definition, see Materials and Methods).
Specimens from patients without any evidence of TB.
Includes only specimens from TB patients.
Includes six unspecific positive smears and 10 smear-positive specimens from patients infected with MOTT.